 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || BCMA-TriCAR-T / Timmune Biotech
New P1 trial, CAR T-Cell Therapy: Treatment of Hematological Malignancy With Novel CAR-T Cells. (clinicaltrials.gov) - Dec 9, 2019
P1, N=9, Recruiting, Sponsor: Timmune Biotech Inc.